Advances in Digital Light Processing (DLP) Bioprinting: A Review of Biomaterials and Its Applications, Innovations, Challenges, and Future Perspectives
Alparslan C., Bayraktar Ş.
Narrative Review, published in Polymers (Basel) (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Polymers (Basel) (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40363070
- PMCID
- PMC12074245
- DOI
- 10.3390/polym17091287
- Citations
- 24
Abstract (original English)
Digital light processing (DLP) technology stands out as a groundbreaking method in the field of biomedical engineering that enables the production of highly precise structures using photopolymerizable materials. Smart materials such as shape memory polymers, hydrogels, and nanocomposites are used as ideal materials for personalized medicine applications thanks to their properties such as superior mechanical strength, biocompatibility, and sensitivity to environmental stimuli in DLP technology. The integration of these materials with DLP enables the production of functional and complex structures, especially in areas such as bone and soft tissue engineering, drug delivery, and biosensor production. However, limited material diversity, scalability problems in production processes, and technical difficulties in optimizing bioprinting parameters are among the main obstacles in this field. This study systematically examines the role of smart biomaterials in DLP-based bioprinting processes. It addresses the innovative applications of these materials in tissue engineering and regenerative medicine. It also comprehensively evaluates its contributions to biomedical applications and discusses future research areas to overcome current limitations.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.